<?xml version="1.0" encoding="UTF-8"?>
<ref id="B34">
 <label>34.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Beigel</surname>
    <given-names>JH</given-names>
   </name>, 
   <name name-style="western">
    <surname>Voell</surname>
    <given-names>J</given-names>
   </name>, 
   <name name-style="western">
    <surname>Kumar</surname>
    <given-names>P</given-names>
   </name>, 
   <name name-style="western">
    <surname>Raviprakash</surname>
    <given-names>K</given-names>
   </name>, 
   <name name-style="western">
    <surname>Wu</surname>
    <given-names>H</given-names>
   </name>, 
   <name name-style="western">
    <surname>Jiao</surname>
    <given-names>JA</given-names>
   </name>, 
   <name name-style="western">
    <surname>Sullivan</surname>
    <given-names>E</given-names>
   </name>, 
   <name name-style="western">
    <surname>Luke</surname>
    <given-names>T</given-names>
   </name>, 
   <name name-style="western">
    <surname>Davey</surname>
    <given-names>RT</given-names>
   </name>
  </person-group>
  <year>2018</year>
  <article-title>Safety and tolerability of a novel, polyclonal human anti-MERS coronavirus antibody produced from transchromosomic cattle: a phase 1 randomised, double-blind, single-dose-escalation study</article-title>. 
  <source>Lancet Infect Dis</source>
  <volume>18</volume>:
  <fpage>410</fpage>â€“
  <lpage>418</lpage>. doi:
  <pub-id pub-id-type="doi">10.1016/S1473-3099(18)30002-1</pub-id>.
  <pub-id pub-id-type="pmid">29329957</pub-id>
 </mixed-citation>
</ref>
